Papers
25
Total Citations
503
H-Index
13
About
James Adshead is a leading British urological surgeon whose research has significantly advanced minimally invasive and robotic urological surgery. His work spans prostate cancer surgery, renal surgery, and iatrogenic urological injury, with particular expertise in optimising functional and oncological outcomes for patients. Adshead is perhaps best known for championing the NeuroSAFE technique in the United Kingdom — a real-time intraoperative frozen-section approach during robot-assisted radical prostatectomy (RARP) that enables surgeons to maximise nerve-sparing while minimising positive surgical margins. His early prospective observational study (73 citations) helped establish NeuroSAFE's feasibility in a British setting, while his landmark multicentre randomised controlled phase 3 trial — the NeuroSAFE PROOF study (2025, 39 citations) — provided rigorous evidence confirming improved erectile function and continence recovery. Beyond prostate cancer, Adshead has contributed meaningfully to robotic renal surgery, including outcomes in solitary kidneys, cystic tumours, and complex partial nephrectomies through large international collaborative databases. His work on pneumoperitoneum's effects on renal physiology (67 citations) has informed safer surgical practice. With contributions to systematic reviews on iatrogenic injury during gynaecological procedures, his research reflects a broad commitment to surgical safety and evidence-based urological care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10